Electrophysiologic effects of salbutamol, a β2-selective agonist

Journal of Cardiovascular Electrophysiology

Volumn 15, Issue 3, 2004, Pages 316-322

  Insulander, Per ^a   Juhlin Dannfelt, Anders ^a   Freyschuss, Ulla ^a   Vallin, Hans ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Beta adrenoceptor; Beta2 agonist; Dobutamine; Electrophysiology; Salbutamol

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; DOBUTAMINE; POTASSIUM; SALBUTAMOL;

ADULT; ARTICLE; BLOOD PRESSURE; CHRONOTROPISM; DRUG SELECTIVITY; FEMALE; HEART ARRHYTHMIA; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM PACING; HEART DEPOLARIZATION; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE EJECTION TIME; HEART PREEJECTION PERIOD; HEART STROKE VOLUME; HEMODYNAMICS; HIS BUNDLE; HUMAN; HUMAN EXPERIMENT; HYPOKALEMIA; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PRIORITY JOURNAL; PURKINJE FIBER; QRS COMPLEX; QT DISPERSION; STATISTICAL ANALYSIS; T WAVE; VAGUS NERVE; VOLUNTEER;

EID: 1842479791     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2004.03105.x     Document Type: Article

References (40)

1. Simonson BG, Stiksa J, Strom B: Double-blind trial with increasing doses of salbutamol and terbutaline aerosols in patients with reversible airway obstruction. Acta Med Scand 1972;192:371-376.
2. Gray BF, Frame M, Costello JF: A comparative double blind study of the bronchodilator effects and side effects of inhaled fenoterol and terbutaline administered in equipotent doses. Br J Dis Chest 1982;76:341-350.
3. Mifune J, Kuramoto K, Ueda K, Matsushita S, Kuwajima I, Sakai M, Iwasaki T, Moroki N, Murakami M: Hemodynamic effects of salbutamol, an oral long-acting beta-stimulant, in patients with congestive heart failure. Am Heart J 1982;104:1011-1015.
4. Bourdillon PDV, Dawson JR, Foale RA, Timmis AD, Poole-Wilson PA, Sutton GC: Salbutamol in treatment of heart failure. Br Heart J 1980;43:206-210.
5. Sharma B, Goodwin JF: Beneficial effects of salbutamol on cardiac function in severe congestive cardiomyopathy. Circulation 1978;58:449-459.
6. Strauss MH, Reeves RA, Smith DL, Leene FHH: The role of cardiac beta-1 receptors in the hemodynamic response to beta-2 agonist. Clin Pharmacol Ther 1986;40:108-115.
7. Levine MAH, Leenen FHH: Role of β1-receptors and vagal tone in cardiac inotropic and chronotropic responses to a β2-agonist in humans. Circulation 1989;79:107-115.
8. Crane J, Burgess C, Beasley R: Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol and isoprenaline. Thorax 1989;44:136-140.
9. Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE: Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet 1990;336:1396-1399.
10. Bennet JA, Smyth ET, Pavord ID, Wilding PJ, Tattersfield AE: Systemic effects of salbutamol and salmeterol in patients with asthma. Thorax 1994;49:771-774.
11. Weissler AM, Harris WS, Schoenfeld CD: Systolic time intervals in heart failure in man. Circ 1968;37:149-159.
12. Coats AJS: Doppler ultrasonic measurement of cardiac output: reproducibility and validation. Eur Heart J 1990;11(Suppl):49-61.
13. Phillips PJ, Vedig AE, Jones PL, Chapman MG, Collins M, Edwards JB, Smeaton TC, Duncan BMcL: Metabolic and cardiovascular side effects of the β2-adrenoceptor agonists salbutamol and rimiterol. Br J Clin Pharmacol 1980;9:483-491.
14. Leier CV, Webel J, Bush CA: The cardiovascular effects of continuous infusion of dobutamine in patients with severe cardiac failure. Circulation 1977;56:468-472.
15. Hjemdahl P: Catecholamine measurements by high performance liquid chromatography with electromechanical detection. Methods Enzymol 1978;142:521-534.
16. Morady F, Nelson SD, Kou WH, Pratley R, Schmaltz S, De Buitleir M, Halter JB: Electrophysiologic effects of epinephrine in humans. J Am Coll Cardiol 1988;11:1235-44.
17. Loeb HS, Sinno MZ, Saudye A, Towne DT, Gunnar RM: Electrophysiologic properties of dobutamine. Circ Shock 1974;1:217-220.
18. Insulander P, Freyschuss U, Juhlin-Dannfelt A, Vallin H: Electrophysiologic effects of mental stress in healthy subjects: A comparison with epinephrine infusion. J Electrocardiol 2003;36:301-309.
19. Vallin H: Autonomous influence on sinus node and AV node function in the elderly without significant heart disease: assessment with electrophysiological and autonomic tests. Cardiovasc Res 1980;14:206-216.
20. Robinson C, Birkhead J, Crook B, Jennings K, Jewitt D: Clinical electrophysiological effects of atenolol: A new cardioselective beta-blocking agent. Br Heart J 1978;40:14-21.
21. Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R, Zera P, Menlove R, Shah P, Jamieson S, Stinson EB: β1-and β2-adrenergic- receptor subpopulations in nonfailing and failing human ventricular myocardium. Circ Res 1986;59:297-309.
22. Brodde OE, Karad K, Zerkowski H-R, Rohm N, Reidemeister JC: Coexistence of β1-and β2-adrenoceptors in human right atrium. Circ Res 1983;53:752-758.
23. Brodde OE, Zerkowski HR, Borst HG: Drug-and disease-induced changes of human cardiac β1-and β2-adrenoceptors. Eur Heart J 1989;10(Suppl B):38-44.
24. Brodde OE, Bruck H, Leineweber K, Syfarth T: Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart. Basic Res Cardiol 2001;96:528-538.
25. Summers RJ, Molnaar P, Russel F, Elnatan J, Jones CR, Buxton BF, Chang V, Hambley J: Coexistence and localisation of β1-and β2-adrenoceptors in the human heart. Eur Heart J 1989;10(Suppl B):11-21.
26. Rodefeld MD, Beau SL, Schuessler RB, Boineau JP, Saffitz JE: β-adrenergic and muscarinic cholinergic receptor densities in the human sinoatrial node. J Cardiovasc Electrophysiol 1996;7:1039-1049.
27. Hall JA, Petch MC, Brown MJ: Intracoronary injections of salbutamol demonstrate the presence of functional β2-adrenoceptors in the human heart. Circ Res 1989;65:546-553.
28. Cannon DS, Rider AK, Stinson EB, Harrison DC: Electrophysiologic studies in the denervated transplanted human heart. Responses to norepinephrine, isoproterenol and propranolol. Am J Cardiol 1975;36:859-66.
29. Leenan FH, Davies RA, Fourney A: Catecholamines and heart function in heart transplant patients: Effects of beta1-versus nonselective beta blockade. Clin Pharmacol Ther 1998;64:522-35
30. Weiss R, Knight BP, Bahu M, Zivin A, Souza J, Goyal R, Daoud E, Man KC, Strickberger SA, Halter JB, Morady F: Cardiac electrophysiologic effects of norepinephrine in human beings. Am Heart J 1998;135(6 Pt 1):945-951.
31. Mancia G, Bonazzi O, Pozzoni L, Ferrari A, Gardumi M, Gregorini L, Perondi R: Baroreceptor control of atrioventricular conduction in man. Circ Res 1979;44:752-758.
32. Gettes LS, Surawicz B, Shiue JC: Effect of high K, low K, and quinidine on QRS duration and ventricular action potential. Am J Physiol 1962;203:1135.
33. Surawicz B, Lepeschkin E, Herrlich HC, Hoffman BF: Effect of potassium and calcium deficiency on the monophasic action potential, electrocardiogram and contractility of isolated rabbit hearts. Am J Physiol 1959;196:1302.
34. Surawicz B: Electrophysiologic Basis of ECG and Cardiac Arrhythmias. Baltimore: Williams & Wilkins, 1995, p. 436.
35. Mettauer B, Rouleau JL, Burgess TH: Detrimental arrhythmogenic and sustained beneficial hemodynamic effects of oral salbutamol in patients with chronic congestive heart failure. Am Heart J 1985;109:840-847.
36. Lowe MD, Rowland E, Brown MJ, Grace AA: Beta(2) adrenergic receptors mediate important electrophysiologic effects in human ventricular myocardium. Heart 2001;86:45-51.
37. Soriano JB, Hoes AW, Meems L, Grobbee DE: Increased survival with beta-blockers: importance of ancillary properties. Prog Cardiovasc Dis 1997;39:445-456.
38. Lechat P, Packer M, Chalon S, et al: Clinical effects of beta-adrenergic blockade in chronic heart failure. Circulation 1998;98:1184-1191.
39. Tandon MK: Cardiopulmonary effects of fenoterol and salbutamol aerosols. Chest 1980;77:429-443.
40. Williams AJ, Weiner C, Reiff D, Swenson ER, Fuller RW, Hughes JM: Comparison of the effect of inhaled selective and non-selective adrenergic agonists on cardiorespiratory parameters in chronic stable asthma. Pulmon Pharmacol 1994;7:235-241.